A couple of years ago, when many were talking about investing in 2024, the markets were at an interesting point. It was late January of that year, and there was quite a bit of upward movement, with inflation already under control and expectations that interest rates would decrease. I was looking at my options to diversify, and honestly, there were companies that were really worth considering.

I started by reviewing Alphabet. This company caught my attention because, in addition to its traditional digital advertising business with Google and YouTube, they were ramping up efforts in artificial intelligence with Gemini. Unlike other tech giants, its valuation was more reasonable, with a P/E of 29 compared to the sector average exceeding 35. Its free cash flow of over $77 billion gave them plenty of flexibility to innovate without pressure. When I looked into investing in 2024, Alphabet was among my top options because of that combination of financial strength and growth potential.

Then there was Nvidia, which frankly dominated the AI chip market with nearly 90% market share. In 2023, it had risen 239% and continued with momentum. Its GPUs were everywhere, from data centers to gaming and autonomous vehicles. It was obvious that it was going to be a key player in the artificial intelligence wave.

Novo Nordisk also interested me quite a bit. They had launched Ozempic, and the anti-obesity medication market was booming, projected to reach $44 billion by 2030. When I thought about investing in 2024, the Danish pharmaceutical company offered exposure to a global health trend that was going to keep growing.

Berkshire Hathaway was the most conservative option. Warren Buffett had $157 billion in cash, which allowed him to act when he saw opportunities. With a beta of 0.64, it moved less than the overall market, making it ideal if you wanted something more stable but with decent return potential.

And then there was Broadcom, which had grown 108% in 2023 and kept climbing. The acquisition of VMware was a strategic move to avoid relying solely on semiconductors. They projected 40% revenue growth for 2024.

The truth is, when I decided to invest in 2024, I had to think about my investment horizon. If it was short-term, CFDs offered ways to speculate on quick movements, but with real risks. For medium and long-term, the key was to select companies with solid fundamentals, diversify well, and not obsess over daily fluctuations.

My strategy was a bit of a mix. I took long positions in these five companies because I believed they would grow, but I also took advantage of specific volatilities with more dynamic instruments. The key was to have a clear entry and exit plan, use stop-losses to protect myself, and stay alert to global events that could move the markets.

Looking back, those decisions to invest in 2024 turned out to be quite accurate. The AI sector exploded as many expected, the pharmaceutical company continued its growth path, and companies with solid fundamentals weathered turbulence well. Diversification was key. It wasn’t just about betting on one sector, but understanding where the real growth was and the long-term opportunities. That’s what I learned from that period.